Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 244 results found since Jan 2013.
Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research
The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018.
“Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news
New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
AAP Approves 2023 Child and Adolescent Immunization Schedule AAP Approves 2023 Child and Adolescent Immunization Schedule
Minor changes and additions to annual ACIP recommendations affected vaccines for COVID-19; dengue fever; pneumococcal disease; and measles, mumps, and rubella.Medscape Medical News
Source: Medscape Allergy Headlines - February 9, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news
Pneumococcal Vaccine Lowers Hospitalization Risk for Elderly Pneumococcal Vaccine Lowers Hospitalization Risk for Elderly
Older adults who received the 13-valent pneumococcal conjugate vaccine were less likely to be hospitalized for pneumonia, a new study found.Medscape Medical News
Source: Medscape Allergy Headlines - December 6, 2022 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians
Clinicians should encourage vaccination against pneumococcal disease as COVID-19 and flu cases rise, researchers say.Medscape Medical News
Source: Medscape Allergy Headlines - November 11, 2022 Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news
The Uncomplicated Course of COVID-19 in Primary Immunodeficiency Patients: A Report of 14 Common Variable Immunodeficiency Patients
According to this study, most of our patients presented with an uncomplicated disease course.PMID:36341567 | DOI:10.18502/ijaai.v21i5.11046
Source: Iranian Journal of Allergy, Asthma and Immunology - November 7, 2022 Category: Allergy & Immunology Authors: Mohammad Nabavi Faezeh Mohammadi Saba Arshi Mohammad Hasan Bemanian Morteza Fallahpour Fatemeh Atashrazm Sima Shokri Source Type: research
